| abstract |
Provided herein are phosphadiazine polymerase inhibitor, for example, of any of Formulas (IV), (IV), (I"), (II"), or (IVa), pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof. |